J

JW Therapeutics 药明巨诺

113 employees

JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2016

Funding rounds raised

Total raised

$100M

from 14 investors over 14 rounds

J

JW Therapeutics 药明巨诺 raised $100M on June 11, 2020

Investors: Mirae Asset MAPS Global Investments Co., Ltd, Temasek, Loyal Valley Capital, CITIC Private Equity Funds Management, ARCH Venture Partners, WuXi AppTec, Sequoia Capital China and Juno Therapeutics, Inc.

J

JW Therapeutics 药明巨诺 raised $90M on March 7, 2018

Investors: Juno Therapeutics, Inc., Temasek, Sequoia Capital China, Yuanming Capital and WuXi AppTec

J

JW Therapeutics 药明巨诺 raised undisclosed on February 1, 2018

Investors: Loyal Valley Capital

FAQ